PEAK6 Investments’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
PEAK6 Investments's ANGO Position: Q3 2021 in Review
PEAK6 Investments sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 68 shares — an estimated $2K sold.
PEAK6 Investments first reported a position in ANGO in Q3 2018 and held it in 5 quarters. The position peaked at $157K in Q4 2018. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.
- PEAK6 Investments reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
- PEAK6 Investments sold 68 AngioDynamics shares in Q3 2021, an estimated $2K.
- PEAK6 Investments first reported a position in AngioDynamics in Q3 2018 and held it in 5 quarters.
- PEAK6 Investments's AngioDynamics position peaked at $157K in Q4 2018.
- 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.
Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.